Accretion Pharmaceuticals Limited (NSE: ACCPL) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹226 Cr, it ranks #2,547 by market cap among the 6,197 Indian listed companies on FinBizNet, and #35 of 63 in Pharmaceuticals.
| Current Price | ₹213.90 |
|---|---|
| Market Cap | ₹226 Cr |
| NSE Symbol | ACCPL |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 23.7 |
| Return on Equity | 27.63% |
| Return on Assets | 14.85% |
| Beta (1Y) | 0.27 |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.accretionpharma.com |
Promoters held 73.52% of Accretion Pharmaceuticals Limited's shares as of Sept 2026, unchanged from Sept 2025.
Accretion Pharmaceuticals Limited engages in the manufacturing and marketing of pharmaceutical products in India. The company offers antibiotic, antibacterial, antifungal, anti-inflammatory, anti-spasmodic, antihistamine, antiallergy, anticough, anticold, antiulcer, gastrointestinal, antacid, anti-diabetic, cardiac, anti-hypertensive, psychotropic, memory enhancer, vitamins, supplements, and other products. It also provides external preparation, oral powder, effervescent formulation, and nutraceutical products, as well as formulations for brain and memory care, neuron care, UTI care, cardiac care, liver care, protein supplement, pediatric care, GIT care, joint and bone care, immunity booster, gynec care, hair and skin care, nail care, and infertility, and PCOS care. The company offers its products in the form of tablets, capsules, oral liquid, ointment, cream, gel, lotion, medicated shampoo, mouthwash, dusting powder, sachet, and dry syrup through contract manufacturing and direct sale
1. Manufacturing and Sale of Pharmaceutical Products-This segment engages in the manufacturing and sale of tablets, capsules, oral liquids, external preparations, oral powders, etc. 2. NA-NA 3. NA-NA 4. NA-NA
1. Manufacturing and Sale of Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹56,531 Cr | 36.3 | 34.46% | ₹1,814 Cr | -8.1% |
| Emcure Pharmaceuticals Ltd | ₹42,344 Cr | 47.9 | 19.57% | ₹2,820 Cr | +73.3% |
| Ajanta Pharma Limited | ₹41,474 Cr | 39.4 | 25.39% | ₹1,794 Cr | +27.8% |
| Piramal Pharma Ltd | ₹32,600 Cr | n/m | -4.00% | ₹2,617 Cr | +22.8% |
| RUBICON RESEARCH LIMITED | ₹28,526 Cr | 112.3 | 19.14% | ₹576 Cr | +162.7% |
| Caplin Point Laboratories Ltdte | ₹18,155 Cr | 28.3 | 19.94% | ₹630 Cr | +23.6% |
| Pfizer Ltd. | ₹17,811 Cr | 24.5 | 17.16% | ₹727 Cr | -24.2% |
| Eris Lifesciences Ltd | ₹17,691 Cr | 28.3 | 18.07% | ₹892 Cr | -17.5% |
| Accretion Pharmaceuticals Limited | ₹226 Cr | 23.7 | 27.63% | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Accretion Pharmaceuticals Limited is trading at ₹213.90, with a market capitalisation of ₹226 Cr.
Accretion Pharmaceuticals Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Accretion Pharmaceuticals Limited has a P/E of 23.7 and a return on equity of 27.63%.
Accretion Pharmaceuticals Limited is listed on the NSE under the symbol ACCPL.
Promoters held 73.52% of Accretion Pharmaceuticals Limited's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.